NCT07478172 Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease Status RECRUITING Phase NA
NCT07411963 Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis Status RECRUITING Phase N/A
NCT07392528 Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/ BCMA(QT-019C) in Patients With r/ r Neurological Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07319689 Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients Status COMPLETED Phase N/A
NCT07304154 A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases Status RECRUITING Phase PHASE1
NCT07294170 ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis Status RECRUITING Phase N/A
NCT07291713 Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program Status COMPLETED Phase NA
NCT07284420 ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod Status RECRUITING Phase PHASE2
NCT07250750 A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis Status RECRUITING Phase PHASE1/PHASE2
NCT07246564 Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis Status RECRUITING Phase PHASE4
NCT07224386 Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis Status NOT_YET_RECRUITING Phase N/A
NCT07217587 Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis Status RECRUITING Phase PHASE3
NCT07217509 PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry Status ENROLLING_BY_INVITATION Phase N/A
NCT07154095 A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT07146425 Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis Status RECRUITING Phase N/A
NCT07136844 Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology Status RECRUITING Phase NA
NCT07125105 Integrating Art Therapy and Adapted Physical Activity: Toward Improved Quality of Life in Patients With Myasthenia Gravis Status NOT_YET_RECRUITING Phase NA
NCT07022197 Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases Status RECRUITING Phase PHASE1/PHASE2